Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany – sources
Unlisted biotech firm CureVac, which is due to receive German state backing, will become the second coronavirus vaccine developer to launch human trials of an experimental immunisation in the country, two people familiar with the plans told Reuters on Tuesday.
